FDA Releases Draft Guidance for Industry on Advisory Committee Meetings Preparation and Public Availability of Information

Summary

The Food and Drug Administration (FDA) has published a draft guidance to help industry sponsors prepare and make available information for advisory committee meetings, aiming to streamline the process and reduce preparation time.